AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Jul 12, 2016
5262_dirs_2016-07-12_d7673497-b334-44ac-b39b-11a7a81388b6.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 9975D
GlaxoSmithKline PLC
12 July 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr D S Redfern
b)
Position/status
Chief Strategy Officer
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each
ISIN: GB0009252882
b)
Nature of the transaction
Acquisition of ordinary shares under the Company's ShareReward Plan
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| £16.7127 | 7 (partnership shares) |
| £16.7127 | 7 (matching shares) |
d)
Aggregated information
Aggregated volume Price
14 Ordinary shares
£16.7127
e)
Date of the transaction
2016-07-11 (12:18 GMT)
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQLLFFQDFXBBV
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'BS-mDjT-UnAnfN_SLTubxEQ6mrsUSDMVh-y6M7OVmJV8OBzwP1FPYzH1MyvuAUdZDEhcO1N3j0QaHcsat4dR0fMjvOFIaS_dmUIqrFq_IUM1:V72dmQ240HMoPEYVwAfwJprHrxzJJ7YB6U0ln_jS1eIb2lvyC2dc05p5W326ohwvyQ3J2rf8CvuHpD8HlFlP6D-3vPcg9ChpoNahfi3AtwA1'}});//]]>